KANGFANG

R&D

Akesobio has the following proprietary platforms: Hybridoma Generation, 3D Humanization, Affinity Maturation, Highly Efficient & High Throughput Screening, and In vivo Efficacy and PK/PD

Equipment: Fortebio SPR, Microplate Reader, BD Calibur Flow cytometer, Mosquito Crystallization Robot, etc.

A.jpg